Karen Flynn

Insider Reports History

Entity
Individual
Location
C/O Catalent, Inc., 14 Schoolhouse Road, Somerset, NJ
Signature
/s/ Alexander Dimitrief, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Flynn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Catalent, Inc. Director Common Stock 24.3K $905K $37.18 Oct 27, 2023 Direct
Quanterix Corp Director Common Stock 26.4K $711K $26.91 Jan 2, 2024 Direct
Sotera Health Co Director Common Stock, $0.01 par value per share ("Common Stock") 20.1K $287K $14.31 May 24, 2024 Direct
Quanterix Corp Director Stock Option (Right to Buy) 6.41K Jan 2, 2024 Direct

Insider Reports Filed by Karen Flynn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SHC Sotera Health Co May 24, 2024 1 $0 4 May 29, 2024 Director
QTRX Quanterix Corp Jan 2, 2024 2 $0 4 Jan 4, 2024 Director
SHC Sotera Health Co Nov 13, 2023 0 $0 3 Nov 21, 2023 Director
CTLT Catalent, Inc. Oct 27, 2023 1 $0 4 Oct 31, 2023 Director
QTRX Quanterix Corp Jan 3, 2023 3 $11.8K 4 Jan 4, 2023 Director
CTLT Catalent, Inc. Oct 27, 2022 1 $0 4 Oct 31, 2022 Director
QTRX Quanterix Corp Oct 3, 2022 1 $11.2K 4 Oct 5, 2022 Director
CTLT Catalent, Inc. Sep 15, 2022 1 $0 4 Sep 19, 2022 Director
CTLT Catalent, Inc. Sep 15, 2022 0 $0 3 Sep 19, 2022 Director
QTRX Quanterix Corp Jul 1, 2022 1 $2.75K 4 Jul 6, 2022 Director
QTRX Quanterix Corp Jun 6, 2022 2 $0 4 Jun 14, 2022 Director
QTRX Quanterix Corp Jun 6, 2022 0 $0 3 Jun 14, 2022 Director
CTLT Catalent, Inc. Jan 10, 2022 1 -$288K 4 Jan 11, 2022 Chief Commercial Officer
CTLT Catalent, Inc. Jul 26, 2021 2 $0 4 Jul 28, 2021 Pres. Biologics & CCO